Source Citation

Cannon CP, Braunwald E, McCabe CH, et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med. 2004;350:1495-504. https://pubmed.ncbi.nlm.nih.gov/15007110

Clinical Impact Ratings

GIM/FP/GP: 7 out of 7

Hospitalists: 6 out of 7

Cardiology: 6 out of 7

References

  • 1 Schwartz GG, Olsson AG, Ezekowitz MD, et al. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. JAMA. 2001;285:1711-8. [PMID: 11277825] Google Scholar
  • 2 Sacks FM, Pfeffer MA, Moye LA, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N Engl J Med. 1996;335:1001-9. [PMID: 8801446] Google Scholar
  • 3 MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20, 536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002;360:7-22. [PMID: 12114036] Google Scholar
  • 4 Grundy SM, Cleeman JI, Merz CN, et al. Implications of recent clinical trials for the national cholesterol education program adult treatment panel III guidelines. Circulation. 2004;110:227-39. [PMID: 15249516] Google Scholar

IMPORTANT: This site is undergoing maintenance for the next 24 hours, starting 3/29/21 at 7:00 PM EDT. Individual users will not be able to log into their accounts to comment
on articles or take CME. Institutional administrators will not be able to make changes. Contact [email protected] with questions.